The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBellevue Health Regulatory News (BBH)

Share Price Information for Bellevue Health (BBH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.20
Bid: 147.00
Ask: 147.60
Change: 4.40 (3.08%)
Spread: 0.60 (0.408%)
Open: 141.40
High: 147.60
Low: 141.40
Prev. Close: 142.80
BBH Live PriceLast checked at -
BB Healthcare is an Investment Trust

To provide Shareholders with capital growth and income over the long term, through investment in listed or quoted global healthcare companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Block Listing Application

3 Oct 2018 10:40

RNS Number : 8452C
BB Healthcare Trust PLC
03 October 2018
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM) OR TO ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA (OTHER THAN THE UNITED KINGDOM OR TO PROFESSIONAL INVESTORS IN IRELAND)

 

3 October 2018

BB Healthcare Trust plc

Block Listing Application

 

The Board of BB Healthcare Trust plc (the "Company") notes that application has been made to the UK Listing Authority and to the London Stock Exchange for a block listing of 25,000,000 ordinary shares of one penny each ("Ordinary Shares") in the Company to be admitted to the Official List and to trading on the London Stock Exchange's market for listed securities ("Admission").

 

The above 25,000,000 Ordinary Shares to be block listed may be issued pursuant to the Company's existing authorities to issue new Ordinary Shares, and subject to the relevant exemptions to issue new shares without issuing a prospectus, and under the BBH Block Scheme 2018. These Ordinary Shares may be issued inter alia to satisfy market demand and for the purposes of managing the premium to net asset value (cum income) per Ordinary Share at which the Ordinary Shares are trading. When issued, these Ordinary Shares will rank pari passu with the existing Ordinary Shares in issue. It is expected that Admission will become effective on 8 October 2018.

 

The Company's LEI is: 213800HQ3J3H9YF2UI82

Enquiries:

 

Peel Hunt LLP

Luke Simpson, Helen Rennardson (Corporate Broking)

Mark Thompson (Sales)

Telephone: +44 (0) 207 418 8900

 

J.P. Morgan Cazenove

James Bouverat, Eddie Nissen (Sales)

Telephone: +44 (0) 207 134 2224

 

Disclaimer

 

This announcement does not constitute a prospectus relating to the Company and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any shares in the Company in any jurisdiction nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with or act as any inducement to enter into, any contract therefor.

 

Peel Hunt LLP ("Peel Hunt") and J.P. Morgan Cazenove, which are authorised and regulated by the Financial Conduct Authority, are acting for the Company only in connection with the matters described in this announcement and are not acting for or advising any other person, or treating any other person as their client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Peel Hunt and J.P. Morgan Cazenove or advice to any other person in relation to the matters contained herein.

 

The shares of the Company have not been and will not be registered under the US Securities Act of 1933, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. Moreover, the shares of the Company have not been, nor will they be, registered under the applicable securities laws of Australia, Canada, the Republic of South Africa, Japan or any member state of the EEA (other than the United Kingdom). Further, the Company will not be registered under the US Investment Company Act of 1940, as amended. Subject to certain exceptions, the shares of the Company may not be offered or sold in the United States, Australia, Canada, the Republic of South Africa, Japan or any member state of the EEA (other than the United Kingdom or to professional investors in Ireland) or to, or for the account or benefit of, any national, resident or citizen of the United States, Australia, Canada, the Republic of South Africa, Japan or any member state of the EEA (other than the United Kingdom or to professional investors in Ireland). The share issuance programme, and the distribution of this announcement, in other jurisdictions may be restricted by law and the persons into whose possession this announcement comes should inform themselves about, and observe, any such restrictions.

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ALSLIFVAIDLVIIT
Date   Source Headline
12th Jan 202410:09 amRNSNet Asset Value(s)
11th Jan 202410:27 amRNSNet Asset Value(s)
10th Jan 202410:04 amRNSNet Asset Value(s)
10th Jan 20247:00 amRNSMonthly Factsheet
9th Jan 202410:08 amRNSNet Asset Value(s)
8th Jan 202410:00 amRNSNet Asset Value(s)
5th Jan 20249:47 amRNSNet Asset Value(s)
4th Jan 20249:53 amRNSNet Asset Value(s)
3rd Jan 202410:02 amRNSNet Asset Value(s)
2nd Jan 202410:01 amRNSNet Asset Value(s)
2nd Jan 20247:00 amRNSTotal Voting Rights
29th Dec 20231:12 pmRNSDirector/PDMR Shareholding
29th Dec 202310:15 amRNSNet Asset Value(s)
28th Dec 202310:06 amRNSNet Asset Value(s)
27th Dec 20239:59 amRNSNet Asset Value(s)
27th Dec 20239:12 amRNSNet Asset Value(s)
22nd Dec 202310:02 amRNSNet Asset Value(s)
21st Dec 202310:02 amRNSNet Asset Value(s)
20th Dec 20239:47 amRNSNet Asset Value(s)
19th Dec 20239:53 amRNSNet Asset Value(s)
18th Dec 202310:02 amRNSNet Asset Value(s)
15th Dec 20239:44 amRNSNet Asset Value(s)
14th Dec 20239:59 amRNSNet Asset Value(s)
13th Dec 20239:55 amRNSNet Asset Value(s)
12th Dec 20239:39 amRNSNet Asset Value(s)
11th Dec 202310:09 amRNSNet Asset Value(s)
8th Dec 20235:00 pmRNSMonthly Factsheet
8th Dec 20239:47 amRNSNet Asset Value(s)
7th Dec 20239:55 amRNSNet Asset Value(s)
6th Dec 202310:18 amRNSNet Asset Value(s)
5th Dec 20232:56 pmRNSNet Asset Value(s)
4th Dec 202310:03 amRNSNet Asset Value(s)
1st Dec 202312:08 pmRNSNet Asset Value(s)
1st Dec 20237:00 amRNSRedemption Price and Total Voting Rights
30th Nov 202310:42 amRNSNet Asset Value(s)
29th Nov 20239:47 amRNSNet Asset Value(s)
28th Nov 20239:50 amRNSNet Asset Value(s)
27th Nov 202310:07 amRNSNet Asset Value(s)
24th Nov 202310:02 amRNSNet Asset Value(s)
23rd Nov 202310:03 amRNSNet Asset Value(s)
22nd Nov 20239:54 amRNSNet Asset Value(s)
21st Nov 202310:15 amRNSNet Asset Value(s)
20th Nov 20232:41 pmRNSResult of GM
20th Nov 202310:04 amRNSNet Asset Value(s)
17th Nov 20239:49 amRNSNet Asset Value(s)
16th Nov 202310:16 amRNSNet Asset Value(s)
15th Nov 20239:54 amRNSNet Asset Value(s)
15th Nov 20239:47 amRNSDirector Declaration
14th Nov 202310:00 amRNSNet Asset Value(s)
13th Nov 20239:59 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.